Jane Street
NAGE

Jane Street’s Niagen Bioscience NAGE Stock Holding History

Jane Street’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9K Buy
12,900
+200
+2% +$1.08K ﹤0.01% 10917
2025
Q4 		$80.8K Buy
+12,700
New +$88.4K ﹤0.01% 10299
2025
Q2 		– Sell
-42,100
Closed -$290K – 11338
2025
Q1 		$290K Buy
42,100
+1,600
+4% +$10.1K ﹤0.01% 7858
2024
Q4 		$215K Buy
+40,500
New +$222K ﹤0.01% 8300
2021
Q4 		– Sell
-16,100
Closed -$101K – 10937
2021
Q3 		$101K Sell
16,100
-69,000
-81% -$569K ﹤0.01% 9290
2021
Q2 		$839K Sell
85,100
-68,900
-45% -$601K ﹤0.01% 6216
2021
Q1 		$1.44M Buy
+154,000
New +$1.22M ﹤0.01% 4699

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's NAGE Position: Q1 2026 in Review

Jane Street sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 357,238 shares — an estimated $1.93M sold.

Jane Street first reported a position in NAGE in Q3 2018 and held it in 15 quarters. The position peaked at $2.27M in Q4 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Jane Street reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 357,238 Niagen Bioscience shares in Q1 2026, an estimated $1.93M.
  • Jane Street first reported a position in Niagen Bioscience in Q3 2018 and held it in 15 quarters.
  • Jane Street's Niagen Bioscience position peaked at $2.27M in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.